ARQL News and Press, ArQule Inc. From 08/30/19

A little clinical data can go a long way. Promising updates from two pipeline assets have catapulted shares of ArQule (NASDAQ: ARQL) 230% higher since the beginning of 2019. The company's market cap soared to $1.3 billion, which is pretty impressive considering it has rarely topped $400 mill...

ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Dr. Marc Schegerin, Chief Financial Officer, will attend Citi’s investor conference on Wednesday, September 4, 2019 at the Four Seasons Hotel in Boston, MA. In addition, Dr. Marc Schegerin wi...

Today, we want to share our analysis of ArQule (ARQL) with you. The company's stock price has declined by over 20% since July despite the absence of company-specific negative news . However, the company has a number of bullish signs including an adequate balance sheet, large institutional own...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...

ArQule, Inc. (ARQL) Q2 2019 Results Earnings Conference Call August 07, 2019, 09:00 AM ET Company Participants Marc Schegerin - Chief Financial Officer Paolo Pucci - Chief Executive Officer Peter Lawrence - President and Chief Operating Officer Brian Schwartz - Head of R&D ...

ArQule ( ARQL -4.7% ) Q2 results : Revenues: $0.3M (-97.8%). More news on: ArQule, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...

ArQule (NASDAQ: ARQL ): Q2 GAAP EPS of -$0.08 beats by $0.01 . More news on: ArQule, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Conference call scheduled today at 9:00 a.m. ET ArQule , Inc. (Nasdaq: ARQL) today announced its financial results for the second quarter of 2019. For the quarter ended June 30, 2019, the Company reported a net loss of $9.1 million, or $0.08 per basic share, compared with net inco...

ArQule, Inc. (Nasdaq:ARQL) today announced that Dr. Brian Schwartz, Chief Medical Officer and Head of Research and Development, will participate in the BTIG Biotechnology Conference on Monday, August 12, 2019 at The St. Regis New York in New York City. About ArQule ArQule is a biopharm...